NSG 6005 WEEK 8
When blood glucose levels are difficult to control in type II diabetes, some form of insulin may be added
to the treatment regimen to control blood glucose and limit complications risks. Which of the following
statements are accurate based on research?
A. Premixed insulin analogues are better at lowering hemoglobin A1c and have less risk for
hypoglycemia.
B. Premixed insulin analogues and the newer premixed insulins are associated with more weight gain
than the oral antidiabetic agents.
C. Newer premixed insulins are better at lowering hemoglobin A1c and postprandial glucose levels than
are long-acting insulins.
D. Patients who are not controlled on oral agents and have postprandial hyperglycemia can have NPH
insulin added at bedtime. - ANSC. Newer premixed insulins are better at lowering hemoglobin A1c and
postprandial glucose levels than are long-acting insulins.
The American Diabetic Association has recommended which of the following tests for ongoing
management of diabetes?
A. Fasting blood glucose
B. Hemoglobin A1c
C. Thyroid function tests
D. Electrocardiograms - ANSB. Hemoglobin A1c
Adam has type I diabetes and plays tennis for his university. He exhibits a knowledge deficit about his
insulin and his diagnosis. He should be taught that:
A. He should increase his CHO intake during times of exercise.
B. Each brand of insulin is equal in bioavailability, so buy the least expensive.
C. Alcohol produces hypoglycemia and can help control his diabetes when taken in small amounts.
D. If he does not want to learn to give himself injections, he may substitute an oral hypoglycemic to
control his diabetes. - ANSA. He should increase his CHO intake during times of exercise.
, Lispro is an insulin analogue produced by recombinant deoxyribonucleic acid (DNA) technology. Which
of the following statements about this form of insulin is not true?
A. The optimal time of preprandial injection is fifteen minutes.
B. The duration of action is increased when the dose is increased.
C. It is compatible with NPH insulin.
D. It has no pronounced peak. - ANSB. The duration of action is increased when the dose is increased.
Unlike most type II diabetics where obesity is a major issue, older adults with low body weight have
higher risks for morbidity and mortality. The most reliable indicator of poor nutritional status in older
adults is:
A. Weight loss in previously overweight persons
B. Involuntary loss of 10% of body weight in less than six months
C. Decline in lean body mass over a twelve-month period
D. Increase in central versus peripheral body adiposity - ANSB. Involuntary loss of 10% of body weight in
less than six months
DPP-4 inhibitors (gliptins) act on the incretin system to improve glycemic control. Advantages of these
drugs include:
A. Better reduction in glucose levels than other classes
B. Less weight gain than sulfonylureas
C. Low risk for hypoglycemia
D. Can be given twice daily - ANSC. Low risk for hypoglycemia
Insulin is used to treat both types of diabetes. It acts by:
A. Increasing beta cell response to low blood glucose levels
B. Stimulating hepatic glucose production
When blood glucose levels are difficult to control in type II diabetes, some form of insulin may be added
to the treatment regimen to control blood glucose and limit complications risks. Which of the following
statements are accurate based on research?
A. Premixed insulin analogues are better at lowering hemoglobin A1c and have less risk for
hypoglycemia.
B. Premixed insulin analogues and the newer premixed insulins are associated with more weight gain
than the oral antidiabetic agents.
C. Newer premixed insulins are better at lowering hemoglobin A1c and postprandial glucose levels than
are long-acting insulins.
D. Patients who are not controlled on oral agents and have postprandial hyperglycemia can have NPH
insulin added at bedtime. - ANSC. Newer premixed insulins are better at lowering hemoglobin A1c and
postprandial glucose levels than are long-acting insulins.
The American Diabetic Association has recommended which of the following tests for ongoing
management of diabetes?
A. Fasting blood glucose
B. Hemoglobin A1c
C. Thyroid function tests
D. Electrocardiograms - ANSB. Hemoglobin A1c
Adam has type I diabetes and plays tennis for his university. He exhibits a knowledge deficit about his
insulin and his diagnosis. He should be taught that:
A. He should increase his CHO intake during times of exercise.
B. Each brand of insulin is equal in bioavailability, so buy the least expensive.
C. Alcohol produces hypoglycemia and can help control his diabetes when taken in small amounts.
D. If he does not want to learn to give himself injections, he may substitute an oral hypoglycemic to
control his diabetes. - ANSA. He should increase his CHO intake during times of exercise.
, Lispro is an insulin analogue produced by recombinant deoxyribonucleic acid (DNA) technology. Which
of the following statements about this form of insulin is not true?
A. The optimal time of preprandial injection is fifteen minutes.
B. The duration of action is increased when the dose is increased.
C. It is compatible with NPH insulin.
D. It has no pronounced peak. - ANSB. The duration of action is increased when the dose is increased.
Unlike most type II diabetics where obesity is a major issue, older adults with low body weight have
higher risks for morbidity and mortality. The most reliable indicator of poor nutritional status in older
adults is:
A. Weight loss in previously overweight persons
B. Involuntary loss of 10% of body weight in less than six months
C. Decline in lean body mass over a twelve-month period
D. Increase in central versus peripheral body adiposity - ANSB. Involuntary loss of 10% of body weight in
less than six months
DPP-4 inhibitors (gliptins) act on the incretin system to improve glycemic control. Advantages of these
drugs include:
A. Better reduction in glucose levels than other classes
B. Less weight gain than sulfonylureas
C. Low risk for hypoglycemia
D. Can be given twice daily - ANSC. Low risk for hypoglycemia
Insulin is used to treat both types of diabetes. It acts by:
A. Increasing beta cell response to low blood glucose levels
B. Stimulating hepatic glucose production
